// App-Quantinova.ai

TCT-209 : Optimal duration of dual antiplatelet therapy after left main coronary artery stenting: A retrospective multicenter AOI LMCA stenting registry

Researchers

Presenter

  • Hiromi Muranishi

Principal Investigators

  • Kyohei Yamaji

  • Yuhei Yamaji

  • Kenji Ando

  • Kazushige Kadota

  • Hirooki Higami

  • Kazuya Kawai

  • Takashi Tamura

  • Hiroki Sakamoto

  • Mamoru Toyofuku

  • Takeshi Morimoto

Medical Centers

  • Shizuoka Cancer Center Hospital, Shizuoka, Japan

  • Kurashiki Central Hospital, Kurashiki, Japan

  • Kitakyushu, Japan

  • Kyoto University, Kyoto, Japan

  • Chikamori Hospital, Kochi, Japan

  • Japanese Red Cross Society Otsu Hospital, Otsu, Japan

  • Otsu Red cross, Otsu, Japan

  • Japan Red Cross Wakayama Medical Center, Wakayama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

  • Left main disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim